CX Daily: Where Covid Vaccine Development Is Going
Cover Story: Where Covid vaccine development is going. Hong Kong’s new chief executive pledges to review IPO rules to attract foreign firms
333 Views
𝛼SK or SearchENTITY
Brii Biosciences (2137 HK)
Brii Biosciences (2137 HK)
36
Analysis
Health Care • China
Brii Biosciences is a biotechnology company focused on developing therapies for infectious and central nervous system diseases. The company has a broad pipeline of therapeutic candidates, with lead programs targeting hepatitis B virus (HBV) infection, and also develops treatments for multi-drug resistant bacterial infections. Brii Biosciences is headquartered in Beijing, China, and was founded in 2017.
morex